Status:
COMPLETED
A Study of the Treatment of Type 2 Diabetes With an Insulin Infusion Pump
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Diabetes
Diabetes Mellitus, Type 2
Eligibility:
All Genders
30-70 years
Phase:
PHASE1
Brief Summary
This trial is conducted in the United States of America (USA). This is an in-patient trial investigating stepwise dose increase in a period of up to 3-weeks followed by a 10-week out-patient maintenan...
Eligibility Criteria
Inclusion
- Type 2 diabetes diagnosis at least 2 years ago
- Body Mass Index (BMI): 26-40 kg/m\^2 (both inclusive)
- HbA1c: 7.5-10% (both inclusive)
- FPG values at least 140 mg/dl (7.8 mmol/l)
Exclusion
- Use of drugs, which may interfere with the interpretation of trial results or are known to cause clinically relevant interference with insulin action or glucose utilization (steroids or non-specific beta-blockers)
- Current addiction to alcohol or substances of abuse or positive results on urine screen for drug and alcohol use
- Known or suspected allergy to trial products or related products
Key Trial Info
Start Date :
June 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2006
Estimated Enrollment :
71 Patients enrolled
Trial Details
Trial ID
NCT00115973
Start Date
June 1 2005
End Date
January 1 2006
Last Update
October 18 2016
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Novo Nordisk Investigational Site
Chula Vista, California, United States, 91911
2
Novo Nordisk Investigational Site
Miami, Florida, United States, 33142
3
Novo Nordisk Investigational Site
Witchita, Kansas, United States, 67214-4942
4
Novo Nordisk Investigational Site
Willingboro, New Jersey, United States, 08046